M F Holick Selected Research

26,26,26,27,27,27- hexafluoro- 1,25- dihydroxyvitamin D3

3/2001	Rationale for use and clinical responsiveness of hexafluoro-1,25-dihydroxyvitamin D3 for the treatment of plaque psoriasis: a pilot study.
7/2000	Hexafluoro-1,25-dihydroxyvitamin D3 has markedly increased potency in inhibiting proliferation of cultured human keratinocytes compared with 1,25-dihydroxyvitamin D3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M F Holick Research Topics

Disease

6	Vitamin D Deficiency 01/2017 - 10/2005
6	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2004 - 07/2000
5	Hypercalcemia (Milk Alkali Syndrome) 01/2017 - 03/2000
5	Neoplasms (Cancer) 03/2007 - 03/2000
3	Prostatic Neoplasms (Prostate Cancer) 03/2007 - 03/2000
2	Erythema 08/2013 - 07/2004
2	Skin Neoplasms (Skin Cancer) 03/2007 - 06/2001
2	Colorectal Neoplasms (Colorectal Cancer) 03/2007 - 05/2001
2	Melanoma (Melanoma, Malignant) 03/2007 - 10/2000
2	Pain (Aches) 01/2006 - 12/2001
2	Colonic Neoplasms (Colon Cancer) 10/2005 - 05/2001
2	Secondary Hyperparathyroidism 07/2004 - 09/2000
1	Hypercalciuria 01/2017
1	Wounds and Injuries (Trauma) 01/2017
1	Overweight 01/2017
1	Multiple Fractures 01/2017
1	Malabsorption Syndromes (Malabsorption Syndrome) 01/2017
1	Chronic Renal Insufficiency 01/2017
1	Rickets (Rachitis) 01/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2016
1	Multiple Sclerosis 12/2014
1	Vascular Diseases (Vascular Disease) 01/2014
1	Osteoporosis 01/2013
1	Crohn Disease (Crohn's Disease) 10/2011
1	Body Weight (Weight, Body) 01/2009
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2007
1	Infections 12/2006
1	Human Influenza (Influenza) 12/2006
1	Respiratory Tract Infections (Respiratory Tract Infection) 12/2006
1	Fibromyalgia (Fibrositis) 01/2006
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2004
1	Muscle Weakness 12/2001
1	Myalgia 12/2001
1	Intestinal Diseases (Diseases, Intestinal) 12/2001
1	Alopecia (Baldness) 08/2001
1	Obesity 09/2000
1	Parathyroid Diseases (Parathyroid Disorders) 03/2000

Drug/Important Bio-Agent (IBA)

18	Vitamin D FDA LinkGeneric 01/2017 - 03/2000
12	hydroxide ionIBA 01/2017 - 03/2000
6	1,25-dihydroxyvitamin DIBA 03/2007 - 05/2001
3	Cholecalciferol (Vitamin D3)FDA Link 08/2013 - 09/2000
2	Calcitriol Receptors (Calcitriol Receptor)IBA 03/2007 - 03/2000
2	AndrogensIBA 03/2007 - 03/2000
2	CalciumIBA 03/2007 - 10/2005
2	Peptides (Polypeptides)IBA 12/2006 - 08/2003
2	Biological ProductsIBA 07/2006 - 07/2004
2	Calcitriol (Calcijex)FDA LinkGeneric 07/2006 - 07/2000
2	paricalcitol (Zemplar)FDA Link 07/2004 - 03/2000
2	Pharmaceutical PreparationsIBA 08/2003 - 06/2001
2	Calcifediol (Calcidiol)FDA Link 05/2001 - 03/2000
2	26,26,26,27,27,27- hexafluoro- 1,25- dihydroxyvitamin D3IBA 03/2001 - 07/2000
1	25-hydroxyvitamin DIBA 01/2016
1	VitaminsIBA 01/2014
1	Vitamin A (Retinol)FDA LinkGeneric 01/2013
1	Insulin-Like PeptidesIBA 01/2009
1	Fish OilsIBA 03/2007
1	Matrix Metalloproteinases (MMPs)IBA 03/2007
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2007
1	Peptide Hydrolases (Proteases)FDA Link 03/2007
1	Cod Liver OilIBA 12/2006
1	Hormones (Hormone)IBA 12/2006
1	SteroidsIBA 12/2006
1	Ointments (Pastes)IBA 07/2004
1	transglutaminase 1IBA 07/2004
1	Parathyroid Hormone-Related ProteinIBA 08/2001
1	Type 1 Parathyroid Hormone Receptor (Parathyroid Hormone Receptor)IBA 08/2001
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2001
1	Petrolatum (Vaseline)FDA Link 03/2001
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 10/2000
1	Messenger RNA (mRNA)IBA 10/2000
1	Ergocalciferols (Ergocalciferol)FDA LinkGeneric 09/2000
1	calcipotriene (calcipotriol)FDA LinkGeneric 07/2000
1	1 alpha,24-dihydroxyvitamin D3 (Tacalcitol)IBA 07/2000

Therapy/Procedure

5	Therapeutics 03/2007 - 03/2000
1	Drug Therapy (Chemotherapy) 08/2001